Outcomes After Tracheal Cannula Removal

NCT ID: NCT06047665

Last Updated: 2024-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-08-25

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This longitudinal observational study involves an integrated knowledge translation (IKT) approach involving key stakeholders in the project team to evaluate the tracheostomy management in patients hospitalized in the Swiss Paraplegic Centre Nottwil (SPC).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary objective

\- to evaluate the rate of physical complications (that require treatment, intubation, recannulation or lead to death) in patients hospitalized in the SPC over three months following the removal of the tracheal cannula (decannulation).

Secondary objectives

* to describe types of complications short-term (up to 4 days) and long-term (up to three months) post-decannulation
* to assess predictors for short- and long-term complications post-decannulation
* to explore patients' perspectives on decannulation outcomes
* to evaluate individual trajectories of the clinical decannulation protocol

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tracheostomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* at the time of recruitment, tracheotomized adult in-patients (≥ 18 years) of the SPC with any medical diagnosis
* decannulated in the Swiss Paraplegic Center Nottwil within the project's data collection period
* German, French, Italian or English as communication language
* study consent

Exclusion Criteria

* patients for whom no decannulation is sought (e.g., due to degenerative illness)
* patients for whom decannulation is planned in a clinic other than the SPC (e.g., patients hospitalized in the SPC for weaning only)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Swiss Paraplegic Research, Nottwil

NETWORK

Sponsor Role collaborator

Katharina Winiker

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Katharina Winiker

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Katharina Winiker, PhD

Role: PRINCIPAL_INVESTIGATOR

Swiss University of Speech and Language Sciences

Gabi Müller Verbiest, PhD

Role: STUDY_CHAIR

Swiss Paraplegic Center Nottwil

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Swiss Paraplegic Center Nottwil

Nottwil, Canton of Lucerne, Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gabi Müller Verbiest, PhD

Role: CONTACT

41 939 55 63 ext. 0041

Katharina Winiker, PhD

Role: CONTACT

58 459 22 78 ext. 0041

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gabi Müller, PhD

Role: primary

41 939 55 63 ext. 0014

Sarah Stierli, BA

Role: backup

41 939 58 92 ext. 0041

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-08

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.